Sign Out
Mezavant XL is intended for once daily, oral administration. The tablets must not be crushed or chewed and should be taken with food.
Adults, including the elderly (>65 years): For induction of remission: 2.4 to 4.8g (two to four tablets) should be taken once daily. The highest dose of 4.8g/day is recommended for patients not responding to lower doses of mesalazine. When using the highest dose (4.8g/day), the effect of the treatment should be evaluated at 8 weeks.
For maintenance of remission: 2.4g (two tablets) should be taken once daily.
Children and adolescents: Mezavant XL is not recommended for use in children below the age of 18 years due to a lack of data on safety and efficacy.
Hepatic or Renal Impairment: Specific studies have not been performed to investigate Mezavant XL in patients with hepatic or renal impairment (see Contraindications and Precautions).
